Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05257161
NA

Carotid Revascularization With MicroNet Covered Stent Comparing Early Neurological Outcomes With Distal Versus Proximal EPS

Sponsor: Meshalkin Research Institute of Pathology of Circulation

View on ClinicalTrials.gov

Summary

The SIBERIA study demonstrated a clear advantage of CGuard stent implantation over the existing classical stent when using a distal anti-embolic device. At the same time, there is no Level 1 evidence for a difference between the proximal and distal anti-embolic device for the CGuard stent.

Official title: Independent Randomized Clinical Trial in Carotid Revascularization With MicroNet Covered Stent (CGuard) Comparing Early Neurological Outcomes With Distal EPS Versus Proximal EPS

Key Details

Gender

All

Age Range

45 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

366

Start Date

2021-11-01

Completion Date

2027-01-01

Last Updated

2022-02-25

Healthy Volunteers

No

Interventions

DEVICE

Emboshield NAV6™

Embolic Protection System for Carotid Artery Revascularization ( distal - filter) + stent CGuardTM™

DEVICE

Mo.Ma™

Embolic Protection System for Carotid Artery Revascularization ( proximal - occlusion) + stent CGuardTM™

Locations (1)

E. Meshalkin National Medical Research Center

Novosibirsk, Russia